Skip to main content
Clinical Trials/ISRCTN10348278
ISRCTN10348278
Active, not recruiting
未知

Studying retinal structure with adaptive optics and function with multifocal electroretinogram

ewcastle upon Tyne Hospitals NHS Foundation Trust0 sites40 target enrollmentNovember 9, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Inherited retinal disease, late-onset retinal degeneration
Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust
Enrollment
40
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2023
End Date
December 31, 2025
Last Updated
last year
Study Type
Other
Sex
All

Investigators

Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Control
  • 1\.1\. Adult between ages of 18 – 80 years old
  • 1\.2\. Capable of performing all of the tests in the study procedures
  • 1\.3\. Able to give informed consent to all of the procedures.
  • 2\. Late\-onset retinal degeneration
  • 2\.1\. Adult between ages of 18 – 80 years old
  • 2\.2\. Capable of performing all of the tests in the study procedures
  • 2\.3\. Able to give informed consent to all of the procedures
  • 2\.4\. Have a confirmed genetic diagnosis of L\-ORD

Exclusion Criteria

  • 1\. Healthy control
  • 1\.1\. Younger than 18 and older than 80 years old
  • 1\.2\. Inability of participant to provide informed consent
  • 1\.3\. Withdrawal of consent
  • 1\.4\. BCVA of less than 6/12 in either eye
  • 1\.5\. Participants with a spherical equivalent of greater than 4 dioptres or astigmatism greater than 2 dioptres
  • 1\.6\. Taking any medication that can affect retinal function (e.g. Hydroxychloroquine, Deferasirox, Vigabatrin).
  • 1\.7\. Known to have any ocular condition that will affect test results/ability to test:
  • 1\.7\.1\. Inherited retinal condition
  • 1\.7\.2\. Glaucoma

Outcomes

Primary Outcomes

Not specified

Similar Trials